A detailed history of Wells Fargo & Company transactions in Dyadic International Inc stock. As of the latest transaction made, Wells Fargo & Company holds 178 shares of DYAI stock, worth $323. This represents 0.0% of its overall portfolio holdings.

Number of Shares
178
Previous 178 -0.0%
Holding current value
$323
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$1.39 - $2.27 $219 - $358
-158 Reduced 47.02%
178 $0
Q1 2024

May 10, 2024

BUY
$1.29 - $1.67 $3 - $5
3 Added 0.9%
336 $0
Q4 2023

Feb 09, 2024

BUY
$1.52 - $2.04 $12 - $16
8 Added 2.46%
333 $0
Q3 2023

Nov 13, 2023

BUY
$1.71 - $2.08 $3 - $4
2 Added 0.62%
325 $0
Q2 2023

Aug 15, 2023

BUY
$1.56 - $2.38 $10 - $16
7 Added 2.22%
323 $0
Q1 2023

May 12, 2023

BUY
$1.25 - $1.86 $2 - $3
2 Added 0.64%
316 $0
Q4 2022

Feb 13, 2023

BUY
$1.18 - $2.32 $3 - $6
3 Added 0.96%
314 $0
Q3 2022

Nov 14, 2022

BUY
$1.65 - $3.42 $100 - $208
61 Added 24.4%
311 $0
Q2 2022

Aug 12, 2022

BUY
$1.85 - $3.22 $11 - $19
6 Added 2.46%
250 $1,000
Q1 2022

May 16, 2022

BUY
$3.01 - $4.81 $3 - $4
1 Added 0.41%
244 $1,000
Q4 2021

Feb 14, 2022

BUY
$3.36 - $5.34 $3 - $5
1 Added 0.41%
243 $1,000
Q3 2021

Nov 15, 2021

SELL
$3.3 - $6.49 $198 - $389
-60 Reduced 19.87%
242 $1,000
Q2 2021

Aug 16, 2021

SELL
$3.35 - $5.67 $68,128 - $115,310
-20,337 Reduced 98.54%
302 $1,000
Q1 2021

May 13, 2021

SELL
$4.75 - $6.87 $75,430 - $109,095
-15,880 Reduced 43.48%
20,639 $113,000
Q4 2020

Feb 09, 2021

SELL
$5.35 - $7.77 $113,799 - $165,275
-21,271 Reduced 36.81%
36,519 $197,000
Q3 2020

Nov 05, 2020

BUY
$7.22 - $9.11 $153,915 - $194,206
21,318 Added 58.45%
57,790 $437,000
Q2 2020

Aug 13, 2020

BUY
$4.93 - $10.26 $32,498 - $67,633
6,592 Added 22.06%
36,472 $316,000
Q1 2020

May 14, 2020

BUY
$2.58 - $6.6 $77,090 - $197,208
29,880 New
29,880 $155,000

Others Institutions Holding DYAI

About DYADIC INTERNATIONAL INC


  • Ticker DYAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,423,100
  • Market Cap $51.7M
  • Description
  • Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...
More about DYAI
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.